Staphylococcal Skin and Soft Tissue Infections

被引：60
作者：
Hatlen, Timothy J. [1 ,2 ,3 ,4 ]
Miller, Loren G. [3 ,4 ,5 ]
机构：
[1] Harbor UCLA Med Ctr, Div Infect Dis, Torrance, CA 90509 USA
[2] Harbor UCLA Med Ctr, Div HIV, Torrance, CA 90509 USA
[3] Harbor UCLA Med Ctr, Lundquist Inst Biomed Innovat, Torrance, CA 90509 USA
[4] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[5] Harbor UCLA Med Ctr, 1000 West Carson St,Box 466, Torrance, CA 90509 USA
来源：
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA | 2021年 / 35卷 / 01期
关键词：
Cellulitis with abscess; Purulent cellulitis; Suppurative cellulitis; Staphylococcus aureus skin infection; Acute bacterial skin and skin structure infections; ACUTE BACTERIAL SKIN; ONCE-WEEKLY DALBAVANCIN; COMPLICATED SKIN; TRIMETHOPRIM-SULFAMETHOXAZOLE; AUREUS INFECTIONS; DOUBLE-BLIND; FUSIDIC ACID; NECROTIZING FASCIITIS; CLINICAL-OUTCOMES; RESISTANT;
D O I：
10.1016/j.idc.2020.10.003
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Staphylococcus aureus is the most common bacteria causing purulent skin and soft tissue infections. Many disease-causing S aureus strains are methicillin resistant; thus, empiric therapy should be given to cover methicillin-resistant S aureus. Bacterial wound cultures are important for characterizing local susceptibility patterns. Definitive antibiotic therapy is warranted, although there are no compelling data demonstrating superiority of any one antibiotic over another. Antibiotic choice is predicated by the infection severity, local susceptibility patterns, and drug-related safety, tolerability, and cost. Response to therapy is expected within the first days; 5 to 7 days of therapy is typically adequate to achieve cure. © 2020 Elsevier Inc.
引用
收藏
页码：81 / 105
页数：25
相关论文
共 106 条
  • [71] Tedizolid Phosphate vs Linezolid for Treatment of Acute Bacterial Skin and Skin Structure Infections The ESTABLISH-1 Randomized Trial
    Prokocimer, Philippe
    De Anda, Carisa
    Fang, Edward
    Mehra, Purvi
    Das, Anita
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (06): : 559 - 569
  • [72] Rabuka Curtis E, 2003, Can J Infect Dis, V14, P210
  • [73] MR-IMAGING IN ACUTE INFECTIOUS CELLULITIS
    RAHMOUNI, A
    CHOSIDOW, O
    MATHIEU, D
    GUEORGUIEVA, E
    JAZAERLI, N
    RADIER, C
    FAIVRE, JM
    ROUJEAU, JC
    VASILE, N
    [J]. RADIOLOGY, 1994, 192 (02) : 493 - 496
  • [74] Microbiology of skin and soft tissue infections in the age of community-acquired methicillin-resistant Staphylococcus aureus
    Ray, G. Thomas
    Suaya, Jose A.
    Baxter, Roger
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2013, 76 (01) : 24 - 30
  • [75] Trends and Characteristics of Culture-Confirmed Staphylococcus aureus Infections in a Large U.S. Integrated Health Care Organization
    Ray, G. Thomas
    Suaya, Jose A.
    Baxter, Roger
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2012, 50 (06) : 1950 - 1957
  • [76] Use of long-acting tetracyclines for methicillin-resistant Staphylococcus aureus infections:: Case series and review of the literature
    Ruhe, JJ
    Monson, T
    Bradsher, RW
    Menon, A
    [J]. CLINICAL INFECTIOUS DISEASES, 2005, 40 (10) : 1429 - 1434
  • [77] Community-onset methicillin-resistant Staphylococcus aureus skin and soft-tissue infections:: Impact of antimicrobial therapy on outcome
    Ruhe, Joerg J.
    Smith, Nathaniel
    Bradsher, Robert W.
    Menon, Anupama
    [J]. CLINICAL INFECTIOUS DISEASES, 2007, 44 (06) : 777 - 784
  • [78] Current and future trends in antibiotic therapy of acute bacterial skin and skin-structure infections
    Russo, A.
    Concia, E.
    Cristini, F.
    De Rosa, F. G.
    Esposito, S.
    Menichetti, F.
    Petrosillo, N.
    Tumbarello, M.
    Venditti, M.
    Viale, P.
    Viscoli, C.
    Bassetti, M.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2016, 22 : S27 - S36
  • [79] Executive Summary: Therapeutic Monitoring of Vancomycin for Serious Methicillin-Resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists
    Rybak, Michael J.
    Le, Jennifer
    Lodise, Thomas P.
    Levine, Donald P.
    Bradley, John S.
    Liu, Catherine
    Mueller, Bruce A.
    Pai, Manjunath P.
    Wong-Beringer, Annie
    Rotschafer, John C.
    Rodvold, Keith A.
    Maples, Holly D.
    Lomaestro, Benjamin M.
    [J]. PHARMACOTHERAPY, 2020, 40 (04): : 363 - 367
  • [80] Efficacy and safety of tigecycline monotherapy compared with vancomycin plus aztreonam in patients with complicated skin and skin structure infections: Results from a phase 3, randomized, double-blind trial
    Sacchidanand, S
    Penn, RL
    Embil, JM
    Campos, ME
    Curcio, D
    Ellis-Grosse, E
    Loh, E
    Rose, G
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2005, 9 (05) : 251 - 261
234567891011